Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 70,425 shares at $50.12 ($3.5M) on 2022-03-24, disclosed to the SEC on 2022-03-24.
Open-market sale of $3.5M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.13 | 819 | $41K | 1.2% |
| 2 | $50.13 | 5,757 | $289K | 8.2% |
| 3 | $50.13 | 5,757 | $289K | 8.2% |
| 4 | $50.25 | 1,344 | $68K | 1.9% |
| 5 | $50.25 | 9,439 | $474K | 13.4% |
| 6 | $50.25 | 9,439 |
| $474K |
| 13.4% |
| 7 | $50.12 | 2,359 | $118K | 3.3% |
| 8 | $50.12 | 2,359 | $118K | 3.3% |
| 9 | $50.12 | 16,576 | $831K | 23.5% |
| 10 | $50.12 | 16,576 | $831K | 23.5% |
| Total | $50.16 avg | 70,425 | $3.5M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |